Buscar resultados de ensayos clínicos
Scleroderma, Systemic - 20 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement Condición: Scleroderma, Systemic Fecha: 2006-06-02 Intervenciones: Drug: Mycophenolate mofetil |
Completed |
Nombre del estudio: Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis Condición: Scleroderma, Systemic Fecha: 2006-07-03 Intervenciones: Drug: High-dose intravenous immunoglobulin (Venoglobulin-IH) |
Terminated |
Nombre del estudio: Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis Condición: Scleroderma, Systemic Fecha: 2007-01-03 Intervenciones:
|
Recruiting |
Nombre del estudio: A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis Condición: Scleroderma, Systemic Fecha: 2015-10-08 Intervenciones:
|
Completed |
Nombre del estudio: Imatinib in Systemic Sclerosis Condición: Scleroderma, Systemic Fecha: 2007-07-24 Intervenciones: Drug: Imatinib mesylate 100 mg orally daily increased by 100 mg/day every 2 weeks to maximum of 400 mg d |
Not yet recruiting |
Nombre del estudio: Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis Condición: Scleroderma, Systemic Fecha: 2017-01-31 Intervenciones:
|
Recruiting |
Nombre del estudio: Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis Condición: Scleroderma, Systemic Fecha: 2015-12-09 Intervenciones: Other: blood samples one blood sample will be done for dos |
Active, not recruiting |
Nombre del estudio: Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis Condición: Scleroderma, Systemic Fecha: 2014-11-03 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis Condición: Scleroderma, Systemic Fecha: 2015-06-15 Intervenciones: Drug: bosentan 62.5 mg oral twice daily for 4 weeks, then 125 mg oral twice daily. |
Not yet recruiting |
Nombre del estudio: Platelet Gel in Systemic Sclerosis Condición: Scleroderma, Systemic Fecha: 2007-04-19 Intervenciones: Drug: Platelet Gel |